Latest medical news · page 231

FDA approves Zaynich (cefepime hydrochloride, zidebactam)

Original new drug approval. powder, intravenous. Sponsor: Wockhardt Bio Ag

FDA expands Afrezza (insulin recombinant human) approval

Efficacy supplement (new or revised indication). powder, inhalation. Sponsor: Mannkind

FDA approves Cavhanza (nilotinib)

Original new drug approval. tablet, orally disintegrating, oral. Sponsor: Flex Pharma

FDA approves Xocova (ensitrelvir)

Original new drug approval. tablet, oral. Sponsor: Shionogi

ETF recommends updating COVID-19 vaccines to target XFG variant

EMA’s Emergency Task Force (ETF) has recommended updating COVID-19 vaccines to target the new SARS-CoV-2 variant XFG for the 2026/2027 vaccination campaign.XFG is part of the…

WHO urges governments to protect young people from addiction to tobacco and nicotine products

Worldwide, at least 40 million children aged 13–15 use tobacco products, and young people’s use of e-cigarettes and nicotine pouches continues to rise. In advance of World No Tobacco Day – 31 May – the World Health Organization (WHO) urges governments around the world to protect a new generation from becoming addicted to tobacco and nicotine products.

Pediatric Care Bed Correction: KayserBetten Issues Correction for KayserBett IDA Beds

If the hand controls to adjust the bed are not locked, children could adjust the bed and become entrapped.

Come to FUTURE: ‘It totally transformed my entire career’

Better Weather Actives LLC Recalls Better Weather Fix Elixir Due to Undeclared Mitragynine and Mitragynine Pseudoindoxyl

FOR IMMEDIATE RELEASE – May 28, 2026 – Sheridan, Wyoming. Better Weather Actives LLC is voluntarily recalling ALL lots of Better Weather Fix Elixir 15 ml because the products may contain undeclared Mitragynine and Mitragynine Pseudoindoxyl (MP). MP is a more potent derivative of Mitragynine, or Kra

Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus

In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic of the Congo, with cases also reported in Uganda, WHO convened several of its expert and advisory groups. These groups assessed potential vaccines and therapeutics for both prevention and treatment of Bundibugyo virus disease (BVD).

Amanita Species Mushroom Poisonings - Northern California, November 2025-March 2026

This report describes an outbreak of 39 cases of amatoxin mushroom poisoning in Northern California.

Characteristics of Patients Hospitalized with Measles During an Outbreak - West Texas, January-March 2025

This report describes characteristics of patients who were hospitalized during a large measles outbreak in west Texas.

Message by the WHO Director-General to the people of the Democratic Republic of the Congo

To the people of DRC, especially to the people of Ituri  Jambo kwenu wakahaji wa Ituri  Mbote na bino, bato ya Ituri  My name is Tedros, and I am the Director-General of the World Health Organization (WHO). But today, I am not writing to you as an official. I am writing to you as someone who knows your region, who has walked your streets, and who cares deeply about what happens to you and your families.  I am writing because I want to be with you in these moments. And I want you to know that you are not alone.  Ebola is not new to me personally. From 2018 to 2020, I…

FDA expands Tremfya (guselkumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech

FDA expands Imfinzi (durvalumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Astrazeneca Uk Ltd

Strengthening public health intelligence through data analytics and artificial intelligence

With so many public health events developing and emerging, it is increasingly important to strengthen public health intelligence to ensure timely detection, assessment and response to potential public health threats.

Cryoprobe Recall: Erbe USA Removes Flexible Cryoprobes

Erbe Cryoprobes may rupture during activation, leading to potential hearing loss, tinnitus, injury, or burns.

Ventilator Correction: Philips Issues Correction for Trilogy Evo Platform Ventilators

Philips Trilogy Evo Ventilators may not function as intended if used with certain nebulizers.

Bazzini Voluntarily Recalls Certain Lots of SkinnyDipped® Dark Chocolate Coconut Almond Bites Due to Undeclared Peanut Allergen

Bazzini, LLC, of Allentown, PA, a co-manufacturer utilized by SkinnyDipped®, is voluntarily recalling a limited number of cases of SkinnyDipped® Dark Chocolate Coconut Almond Bites, out of an abundance of caution, due to the possible presence of undeclared peanut allergen. People who have allergies

DE DIOS’S ICE POPS II LLC Issues Allergy Alert on Undeclared Milk, Pecans, Pistachio, Yellow #5, and Red #40 in Popsicles

PATERSON, N.J. – DE DIOS’S ICE POPS II LLC is voluntarily recalling its 3.7 oz. packages of “popsicles” food treats because they may contain undeclared MILK, YELLOW #5, RED #40, PECANS, AND PISTACHIOS. People who have an allergy or

New Alert: Growing number of Salmonella illnesses and outbreaks linked to moringa leaf products

New Alert: Growing number of Salmonella illnesses and outbreaks linked to moringa leaf products

Alert Update: Growing number of Salmonella illnesses and outbreaks linked to moringa leaf products

Alert Update: Growing number of Salmonella illnesses and outbreaks linked to moringa leaf products

Cesarean Delivery on Request

Cesarean delivery on maternal request requires individualized counseling. Reduced risks of pelvic floor disorders should be weighed against surgical risks and future risks including abnormal placentation. Author Marianna Alperin, MD, MS, from UC San Diego School of Medicine, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD. Related Content: Cesarean Delivery on Maternal Request Cesarean Delivery—Reply Cesarean Delivery

NEJM This Week — May 28, 2026

This week, we present new research guiding treatment of pulmonary embolism, early progress in cardiac regeneration with engineered heart tissue, and treatments for gastroesophageal cancer and Chiari malformation. We review leishmaniasis and follow a revealing neurologic case. Perspectives discuss nutrition policy, tickborne illness, structural competence in medicine, and the arrival of closure.